Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Benzinga

Vertex Pharmaceuticals Stock Dives After Q2 Earnings, Phase 2 Results For VX-993

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reported financial results for the second quarter after the market close on Monday. Here’s a rundown of the report.

Benzinga

At 37, He Spent 20 Years Chasing FIRE For Him And His Family And Finally Got There. Now His Wife Says She's Changed Her Mind

A man who spent his entire adult life chasing early retirement says he’s heartbroken after finally reaching his goal, only to be told by his wife that she no longer wants him to retire.

Benzinga

Palantir Q2 Earnings: Revenue, EPS Beat Estimates, Company Raises Guidance Citing 'Astonishing Impact' Of AI Leverage

Palantir Technologies Inc (NASDAQ:PLTR) reported financial results for the second quarter after the market close on Monday. Here’s a look at the key details from the AI software company’s report.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Bitcoin Holds Steady As Ethereum, XRP, Dogecoin Lead Altcoin Rally

Cryptocurrency markets are rallying on Monday, led by notable Ethereum outperformance.

Benzinga

Trump Is Playing With Inflation Data, People Say—Here's What We Know

Whispers of government manipulation are swirling after a quiet change in how inflation is measured.

Benzinga

Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

What if a biotech company could flip its financial narrative from loss to profit in just a year? Twist Bioscience Corporation (NASDAQ:TWST) has done just that, reporting a surprising third-quarter income that defied analysts’ expectations

Benzinga

Options Corner: Why Royal Gold Presents A Compelling Reversal Narrative For High-Risk Gamblers

With earnings season in full bloom, one company that doesn't look particularly enticing on surface level is Royal Gold Inc. (NASDAQ:RGLD). While RGLD stock is easily beating the benchmark Nasdaq Composite index this year, it has floundered since early July. Ahead of its second-quarter disclosure scheduled for release this Wednesday…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

'Yeah, Most Of It — Like Down To The 10%,' Kevin Jonas Says Of Losing His Fortune Before The Jonas Brothers' Comeback

A decade ago, pop musician Kevin Jonas learned how quickly money can vanish. He said a misjudged property partnership erased 90% of the wealth he built during the Jonas Brothers' first chart‑topping run. When asked about the financial fallout during an interview on Lewis Howes' "School of Greatness" podcast, Jonas…

Benzinga

Opendoor Becomes Meme Stock Royalty Ahead Of Earnings, These ETFs Hold The Keys (CORRECTED)

Editor’s note: This article has been updated to reflect recent changes in ETF offerings.

Benzinga

Opendoor Q2 Preview: Newly Minted Meme Stock Tries To Win New Investors With Results, Turnaround Efforts

Online home buying and seller Opendoor Technologies Inc (NASDAQ:OPEN) could gain new investors or strengthen its meme stock status when the company reports second-quarter financial results after market close Tuesday.

Benzinga

Trump Says Sweeney's Ad Is 'HOTTEST' — American Eagle Stock Goes Wild

American Eagle Outfitters Inc. (NYSE:AEO) surged as much as 20% by early afternoon Monday after an unexpected endorsement from President Donald Trump lit up Truth Social — and the stock market.

Benzinga

Stocks That Soared The Last Time Markets Were This Wobbly

As I have warned all summer, the noise from the news just keeps getting louder.

Benzinga

Stock Of The Day: Breakout Time For D.R. Horton?

D.R. Horton, Inc. (NYSE:DHI) shares are trading higher on Monday. They may be on the verge of a breakout, and if this happens, there is a good chance a new uptrend forms.

Benzinga

Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) stock experienced a volatile trading session on Monday, after the company announced positive topline results from its Phase 2 RADIANT study evaluating vormatrigine in patients with focal onset seizures and generalized epilepsy.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Disney's 3 Marvel Movies In 2025 May Have Anything But 'Fantastic' Box Office Performance

When it comes to releasing superhero movies in the Marvel Cinematic Universe, The Walt Disney Company (NYSE:DIS) may want to adopt the "quality over quantity" mantra.

Benzinga

Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results

U.S. stocks traded higher midway through trading, with the SP 500 gaining more than 1% on Monday.

Benzinga

Wall Street's Fear Gauge Just Crashed—These 3 ETFs Are Cashing In

The CBOE Volatility Index (VIX) tumbled over 12% on Monday to around 17.88, erasing most of last week's surge and fueling a swift rally in ETFs designed to profit when fear fades.

Benzinga

It Isn't 2007 — Suze Orman Says You Need To Automate This Key Part Of Your Financial Life

In 2007, financial empowerment often meant keeping a stack of bills on the kitchen counter, logging into multiple accounts every month, and crossing your fingers you didn't miss a due date. But personal finance expert Suze Orman says those days are long gone — and there’s no excuse not to…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Wall Street Rebounds Ahead Of Palantir Earnings: What's Moving Markets Monday?

U.S. stocks bounced back sharply Monday, recovering from Friday's sell-off triggered by renewed concerns over a weakening labor market.

Benzinga

Billions Are Flowing Into SPY While IVV Bleeds—Same Index, Different Story

ETF investors have been showing plenty of love for the SP 500, but it seems like not all SP 500 ETFs are created equal in their eyes.

Benzinga

Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide

TG Therapeutics Inc. (NASDAQ:TGTX) stock is trading lower on Monday after the company reported worse-than-expected second-quarter 2025 earnings.

Benzinga

Can Super Micro's AI Demand Outpace Profit Margin Fears?

Super Micro Computer (NASDAQ:SMCI) is navigating a complex market landscape as it prepares to report its fiscal fourth-quarter earnings with a significant long-term growth narrative in the AI server space tempered by immediate concerns about market visibility and sustained pressure on profit margins.

Benzinga

Why Is Replimune Stock Trading Lower On Monday?

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.

Benzinga

Why This Analyst Thinks Uber Is Set For A Strong Q2

BoA Securities analyst Justin Post maintained a Buy rating on Uber Technologies Inc (NYSE:UBER) with a price target of $115 on Monday.

Benzinga

No Steady Paycheck? Here's How Real People Budget With Volatile Incomes—And Stay Financially Sane

If you work at a regular job, chances are you make the same income each month. That level of predictability makes it easy to allocate each paycheck across various expenses. However, some people have volatile incomes that are based on seasonal changes, industrial trends, and other factors that are outside…

1 … 42 43 44 45

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.